Article (Scientific journals)
Occurrence of progressive pulmonary fibrosis and its association with survival in connective tissue disease-associated interstitial lung disease: an international retrospective cohort study.
Guiot, Julien; Teitsma, Xavier M; Dimitroulas, Theodoros et al.
2026 • In Rheumatology International, 46 (10)
Peer Reviewed verified by ORBi
 

Files


Full Text
20260928_depict_e456f0f8-aa5d-4862-9bed-0dcfbe209ae9.pdf
Author postprint (1.28 MB) Creative Commons License - Attribution
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Connective tissue diseases; Interstitial lung diseases; Pulmonary fibrosis; Retrospective studies; Rheumatoid arthritis; Systemic scleroderma; Adrenal Cortex Hormones; Humans; Female; Middle Aged; Retrospective Studies; Male; Disease Progression; Aged; Adrenal Cortex Hormones/therapeutic use; Risk Factors; Lung Diseases, Interstitial/mortality; Lung Diseases, Interstitial/drug therapy; Lung Diseases, Interstitial/etiology; Lung Diseases, Interstitial/physiopathology; Connective Tissue Diseases/complications; Connective Tissue Diseases/mortality; Pulmonary Fibrosis/etiology; Pulmonary Fibrosis/mortality; Pulmonary Fibrosis/epidemiology; Pulmonary Fibrosis/drug therapy; Pulmonary Fibrosis/physiopathology
Abstract :
[en] To describe real-world management of connective tissue disease-associated interstitial lung disease (CTD-ILD) and explore associations between progressive pulmonary fibrosis (PPF) onset and clinical outcomes. This international, retrospective cohort included adults with rheumatoid arthritis (RA), systemic sclerosis (SSc), mixed connective tissue disease, and other CTD with associated ILD. PPF was identified using INBUILD and/or ATS/ERS/JRS/ALAT criteria applied in routine care. Analyses were descriptive and exploratory; time-to-event methods assessed selected outcomes and factors associated with PPF onset. Among 357 patients (mean age 61.6 years; 58% female), SSc-ILD (31%) and RA-ILD (29%) were most common. At ILD diagnosis, 21.6% had no respiratory symptoms. During a mean follow-up of 60.5 months, 147 patients (41.2%) met the PPF criteria, at a median of 30.6 months after CTD-ILD diagnosis. Following PPF onset, the most frequently prescribed therapies were corticosteroids (72.8%), mycophenolate mofetil (52.4%), and antifibrotics (51.0%). Lung function data were available for 37.8% at diagnosis and 53.7% at year 5. PPF was associated with greater observed lung function decline compared to non-PPF patients. ILD-related hospitalizations was numerically more frequent within PPF patients (37.4% vs. 28.6%), but the difference was not statistically significant (P = 0.078). Among patients with PPF, earlier versus later onset, defined by a subtype-specific median split, was associated with poorer observed survival (P < 0.001). In this retrospective cohort, PPF was observed frequently in CTD-ILD patients, particularly those with SSc-ILD, and was associated with greater lung function decline and higher healthcare utilisation. Earlier PPF onset was associated with higher mortality risk, but missing lung function data, surveillance differences, time-related bias, and residual confounding limit causal interpretation. Prospective studies using harmonised PPF adjudication and time-dependent analyses are needed.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Guiot, Julien  ;  Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Teitsma, Xavier M ;  Boehringer Ingelheim B.V., Basisweg 10, 1043 AP, Amsterdam, The Netherlands. xavier.teitsma@boehringer-ingelheim.com
Dimitroulas, Theodoros ;  4th Department of Internal Medicine, Hippokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Davidsen, Jesper Rømhild ;  South Danish Center for Interstitial Lung Diseases (SCILS), Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark
Patabendige, Sanjeewa ;  South Danish Center for Interstitial Lung Diseases (SCILS), Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark
Silva, Lidia;  TFS HealthScience, Madrid, Spain
Nibbering, Karin;  Boehringer Ingelheim B.V., Basisweg 10, 1043 AP, Amsterdam, The Netherlands
Haaksma-Herczegh, Monika;  Boehringer Ingelheim B.V., Basisweg 10, 1043 AP, Amsterdam, The Netherlands
Duarte, Ana Catarina ;  Department of Rheumatology, Hospital Garcia de Orta, Unidade Local de Saúde de Almada-Seixal, Almada, Portugal
Prata, Ana Rita Luis Alves ;  Department of Rheumatology, Unidade Local de Saúde Região de Aveiro, Ovar, Portugal
Wuyts, Wim A ;  Unit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium
Language :
English
Title :
Occurrence of progressive pulmonary fibrosis and its association with survival in connective tissue disease-associated interstitial lung disease: an international retrospective cohort study.
Publication date :
26 September 2026
Journal title :
Rheumatology International
ISSN :
0172-8172
eISSN :
1437-160X
Publisher :
Springer Science and Business Media LLC, Germany
Volume :
46
Issue :
10
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
Boehringer Ingelheim
Available on ORBi :
since 28 September 2026

Statistics


Number of views
30 (2 by ULiège)
Number of downloads
72 (1 by ULiège)

OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi